Big fine for Nurofen in Australia over misleading claims

December 16, 2016

Drug giant Reckitt Benckiser was slapped with a Aus$6 million (US$4.4 million) fine Friday for making misleading claims about its popular Nurofen Specific Pain brand in Australia.

The country's consumer watchdog took action against the company in 2015, disputing Nurofen packaging claims that products in the range were formulated to treat different types of , when the was identical.

The Federal Court last year ruled the British-based multinational engaged in deceptive conduct between 2011 and 2015 with the main ingredient, ibuprofen lysine, the same in all the products with none better at treating one type of pain than others.

It fined the group Aus$1.7 million, but the Australian Competition and Consumer Commission (ACCC) appealed, claiming it was inadequate and did not serve as an effective deterrent.

The court Friday revised the penalty to Aus$6 million "to ensure that Reckitt Benckiser and other 'would-be wrongdoers' think twice and decide not to act against the strong public interest".

ACCC chairman Rod Sims said a bigger fine was appropriate "given the longstanding and widespread nature of the conduct, and the substantial sales and profit that was made".

The case revolved around Nurofen Back Pain, Nurofen Period Pain, Nurofen Migraine Pain and Nurofen Tension Headache products.

The original ruling ordered that they be removed from retail shelves and packets amended.

Nurofen denied it deliberately deceived consumers and said it had cooperated with the ACCC throughout.

In Australia, Reckitt Benckiser markets and supplies a range of consumer health and household brands, including Nurofen, Mortein, Clearasil, Finish, Airwick and Gaviscon.

Explore further: Australia challenges 'misleading' Nurofen painkiller

Related Stories

Australia challenges 'misleading' Nurofen painkiller

March 5, 2015
Australia's consumer watchdog Thursday launched court action against drug giant Reckitt Benckiser, alleging false or misleading claims about its popular painkiller Nurofen.

Australia court: UK company misled consumers over painkiller

December 14, 2015
An Australian court ordered a British consumer goods company on Monday to remove several versions of a popular painkiller from stores in Australia after ruling that the company misled consumers about the products' effectiveness.

British watchdog probes Nurofen adverts

December 15, 2015
Britain's advertising watchdog said Tuesday it was investigating a TV advert for Nurofen after some versions of the painkiller were removed from shelves in Australia over misleading claims.

Painkiller recalled in Britain after suspected sabotage

August 27, 2011
The makers of painkiller Nurofen Plus have recalled the tablets in Britain after anti-psychotic and epilepsy drugs were found to have been placed in packets in acts of suspected sabotage.

Man held in Britain over contamination of painkillers

September 23, 2011
British police arrested a man on Friday after anti-psychotic and epilepsy drugs were placed in packets of the painkiller Nurofen Plus, Scotland Yard said.

Ibuprofen-codeine misuse a health risk

September 18, 2013
(Medical Xpress)—Researchers have recommended that drugs combining codeine and other pain killers, such as paracetamol or ibuprofen, be restricted to prescription-only following reports of misuse and fatalities.

Recommended for you

Complex inhalers prevent patients from taking medicine

February 23, 2018
Respiratory disease patients with arthritis could struggle to manage their conditions because their inhalers are too fiddly for them to use, University of Bath research has found.

Sweet, bitter, fat: New study reveals impact of genetics on how kids snack

February 22, 2018
Whether your child asks for crackers, cookies or veggies to snack on could be linked to genetics, according to new findings from the Guelph Family Health Study at the University of Guelph.

Opioid abuse leads to heroin use and a hepatitis C epidemic, researcher says

February 22, 2018
Heroin is worse than other drugs because people inject it much sooner, potentially resulting in increased risk of injection-related epidemics such as hepatitis C and HIV, a Keck School of Medicine of USC study shows.

The good and bad health news about your exercise posts on social media

February 22, 2018
We all have that Facebook friend—or 10—who regularly posts photos of his or her fitness pursuits: on the elliptical at the gym, hiking through the wilderness, crossing a 10K finish line.

Smartphones are bad for some teens, not all

February 21, 2018
Is the next generation better or worse off because of smartphones? The answer is complex and research shows it largely depends on their lives offline.

Tackling health problems in the young is crucial for their children's future

February 21, 2018
A child's growth and development is affected by the health and lifestyles of their parents before pregnancy - even going back to adolescence - according to a new study by researchers at the Murdoch Children's Research Institute, ...

0 comments

Please sign in to add a comment. Registration is free, and takes less than a minute. Read more

Click here to reset your password.
Sign in to get notified via email when new comments are made.